Name: Reshaping kidney care – Establishing the full potential of SGLT2 inhibitors as standard-of-care
Start: 2023-06-17T08:00:00+00:00
End: 2023-06-17T17:00:00+00:00

April 15, 2023

Reshaping kidney care – Establishing the full potential of SGLT2 inhibitors as standard-of-care

Quick summary – Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Faculty

Kieran McCafferty

Nephrologist,

Barts Health NHS Trust, UK

David Cherney

Nephrologist,

University of Toronto, Canada

Paola Fioretto

Endocrinologist,

University of Padova, Italy

Agenda

Duration (mins)	Session title	Faculty
5	Welcome and introductions	Kieran McCafferty
10	From early to late in CKD – nephrologists and their role before secondary care	Kieran McCafferty
15	Time to make flozination as standard-of-care	David Cherney
15	Overcoming barriers to the use of SGLT2 inhibitors – learnings from our journey so far	Paola Fioretto
10	Panel discussion and Q&A	All faculty
5	Closing remarks	Kieran McCafferty

Programme information

Please note you must register for the 60^th European Renal Association Conference to access this event.Register for ERA conference here: https://www.era-online.org/events/milan-2023/

The educational content is intended for Nephrologists.

This symposium is endorsed by University Medical Center Groningen and accredited for 1 CPD credit by the Royal College of Physicians.

Supported by an unrestricted educational grant from AstraZeneca.

Reshaping kidney care – Establishing the full potential of SGLT2 inhibitors as standard-of-care

Faculty

Kieran McCafferty

Nephrologist,

Barts Health NHS Trust, UK

David Cherney

Nephrologist,

University of Toronto, Canada

Paola Fioretto

Endocrinologist,

University of Padova, Italy

Agenda

This site is intended for HCPs only and is a free resource that provides independent education.